BR9915822B1 - derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência - Google Patents
derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotênciaInfo
- Publication number
- BR9915822B1 BR9915822B1 BRPI9915822-1B1A BR9915822A BR9915822B1 BR 9915822 B1 BR9915822 B1 BR 9915822B1 BR 9915822 A BR9915822 A BR 9915822A BR 9915822 B1 BR9915822 B1 BR 9915822B1
- Authority
- BR
- Brazil
- Prior art keywords
- impotence
- treatment
- pharmaceutical composition
- derivatives
- pyrazolopyrimidinone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19980048100 | 1998-11-11 | ||
KR19990014972 | 1999-04-27 | ||
KR19990049384A KR100353014B1 (ko) | 1998-11-11 | 1999-11-09 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
PCT/KR1999/000675 WO2000027848A1 (en) | 1998-11-11 | 1999-11-10 | Pyrazolopyrimidinone derivatives for the treatment of impotence |
Publications (3)
Publication Number | Publication Date |
---|---|
BR9915822A BR9915822A (pt) | 2001-08-14 |
BR9915822B1 true BR9915822B1 (pt) | 2013-08-27 |
BRPI9915822B8 BRPI9915822B8 (pt) | 2021-05-25 |
Family
ID=27349839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9915822A BRPI9915822B8 (pt) | 1998-11-11 | 1999-11-10 | derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência |
Country Status (17)
Country | Link |
---|---|
US (1) | US6583147B1 (pt) |
EP (1) | EP1129093B1 (pt) |
JP (1) | JP3577630B2 (pt) |
KR (1) | KR100353014B1 (pt) |
CN (1) | CN1136219C (pt) |
AT (1) | ATE245650T1 (pt) |
AU (1) | AU760422B2 (pt) |
BR (1) | BRPI9915822B8 (pt) |
CA (1) | CA2350538C (pt) |
DE (1) | DE69909818T2 (pt) |
DK (1) | DK1129093T3 (pt) |
ES (1) | ES2204169T3 (pt) |
HK (1) | HK1039328B (pt) |
NZ (1) | NZ511015A (pt) |
PT (1) | PT1129093E (pt) |
TR (1) | TR200101335T2 (pt) |
WO (1) | WO2000027848A1 (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60040878D1 (de) * | 1999-06-23 | 2009-01-02 | Pasteur Institut | Zusammensetzungen zur Behandlung von beeinträchtigten zwischenmenschlischen Störungen und Verhaltenstörungen |
YU59100A (sh) * | 1999-10-11 | 2003-10-31 | Pfizer Inc. | Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera |
KR100377782B1 (ko) * | 2000-06-23 | 2003-03-29 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법 |
DE60222931T2 (de) * | 2001-12-13 | 2008-07-10 | Asubio Pharma Co., Ltd. | Pyrazolopyrimidinonderivate mit pde7-hemmender wirkung |
KR20070091049A (ko) | 2002-12-13 | 2007-09-06 | 워너-램버트 캄파니 엘엘씨 | 하부요로증상을 치료하기 위한 알파-2-델타 리간드 |
EP1605925A1 (en) * | 2003-03-17 | 2005-12-21 | Pfizer Products Inc. | Treatment of type 1 diabetes with pde5 inhibitors |
CN100374441C (zh) | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途 |
JP2007518788A (ja) | 2004-01-22 | 2007-07-12 | ファイザー・インク | バソプレッシンのアンタゴニスト活性を阻害するトリアゾール誘導体 |
US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
ZA200707506B (en) * | 2005-02-18 | 2009-08-26 | Surface Logix Inc | Method of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds |
CN102351862A (zh) * | 2005-02-18 | 2012-02-15 | 表面线段公司 | 药动学改善的化合物 |
ES2433661T3 (es) | 2005-04-19 | 2013-12-12 | Takeda Gmbh | Roflumilast para el tratamiento de hipertensión pulmonar |
CN101193636B (zh) * | 2005-06-10 | 2011-12-28 | 东亚制药株式会社 | 吡唑并嘧啶酮衍生物在制备用于预防和治疗肝病的药剂中的应用 |
CN1966506A (zh) * | 2005-11-17 | 2007-05-23 | 上海特化医药科技有限公司 | 吡唑并嘧啶酮衍生物及其制备方法和用途 |
AU2006341342B2 (en) * | 2006-04-04 | 2010-05-20 | Dong-A Pharmaceutical.Co., Ltd. | Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
EP2024369A4 (en) * | 2006-06-05 | 2010-10-27 | Matrix Lab Ltd | NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE |
AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
AU2007293885A1 (en) | 2006-09-07 | 2008-03-13 | Takeda Gmbh | Combination treatment for diabetes mellitus |
US20090270425A1 (en) * | 2006-10-20 | 2009-10-29 | Concert Pharmaceuticals Inc. | 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
KR20090091138A (ko) * | 2006-10-20 | 2009-08-26 | 콘서트 파마슈티컬즈, 인크. | 3―(디히드로―1H―피라졸로〔4,3―d〕피리미딘―5―일)―4―프로폭시벤젠설폰아미드 유도체 및 이의 사용방법 |
US20090197899A1 (en) * | 2006-10-20 | 2009-08-06 | Concert Pharmaceuticals Inc. | 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use |
WO2008100886A1 (en) * | 2007-02-12 | 2008-08-21 | Auspex Pharmaceuticals, Inc. | Preparation and use of deuterated udenafil analogues as highly selective pde5 modulators for the treatment of erectile dysfunction |
US8563000B2 (en) | 2007-05-25 | 2013-10-22 | Ipsen Pharma S.A.S. | Melanocortin receptor ligands modified with hydantoin |
AU2008259342B2 (en) | 2007-06-04 | 2014-07-10 | Ben-Gurion University Of The Negev Research And Development Authority | Tri-aryl compounds and compositions comprising the same |
KR101002490B1 (ko) * | 2007-06-09 | 2010-12-17 | 동아제약주식회사 | 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물 |
AU2008307905A1 (en) * | 2007-10-02 | 2009-04-09 | Dond-A Pharm.Co., Ltd. | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
KR100920125B1 (ko) * | 2007-10-02 | 2009-10-01 | 동아제약주식회사 | 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물 |
WO2009099620A1 (en) * | 2008-02-04 | 2009-08-13 | Concert Pharmaceuticals Inc. | 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
KR20090087795A (ko) * | 2008-02-13 | 2009-08-18 | 한양대학교 산학협력단 | 혈관 재협착 예방 및 치료를 위한 약학 조성물 및 이를포함하는 스텐트 |
KR101071877B1 (ko) * | 2009-02-18 | 2011-10-10 | 동아제약주식회사 | 유데나필 산부가염, 그의 제조방법 및 이를 포함하는 약학적 조성물 |
GB0903493D0 (en) | 2009-02-27 | 2009-04-08 | Vantia Ltd | New compounds |
EP2556820A4 (en) | 2010-04-05 | 2015-01-21 | Sk Chemicals Co Ltd | COMPOSITION CONTAINING PDE5 INHIBITOR FOR MITIGATION OF SKIN WRINKLES |
CN102952138B (zh) | 2011-08-17 | 2016-07-06 | 上海特化医药科技有限公司 | 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用 |
CN104168895B (zh) | 2012-02-28 | 2020-02-21 | 首尔制药株式会社 | 包含西地那非作为活性成分的掩蔽苦味的高含量快速溶解膜 |
KR101953735B1 (ko) | 2012-12-14 | 2019-03-04 | 한미약품 주식회사 | 포스포다이에스터라제-5 억제제를 포함하는 츄정 |
CA2928725A1 (en) | 2013-11-05 | 2015-05-14 | Esther Priel | Compounds for the treatment of diabetes and disease complications arising from same |
KR20240122604A (ko) | 2014-08-12 | 2024-08-12 | 주식회사 메지온 | 유데나필 조성물을 이용하여 폰탄 환자에서 심근 성능을 개선시키는 방법 |
KR101645652B1 (ko) | 2014-11-03 | 2016-08-08 | (주)퓨젠바이오농업회사법인 | 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 성기능개선용 조성물 |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
CN107759603B (zh) * | 2016-08-18 | 2020-09-01 | 四川科伦药物研究院有限公司 | 一种杂环化合物的制备方法 |
CN113493459B (zh) * | 2020-04-07 | 2022-12-13 | 广州白云山医药集团股份有限公司白云山制药总厂 | Pde5抑制剂化合物及其制备方法和应用 |
EP4259634A1 (en) | 2020-12-11 | 2023-10-18 | Ildong Pharmaceutical Co., Ltd. | Novel compounds as androgen receptor and phosphodiesterase dual inhibitor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9114760D0 (en) * | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
GB9119704D0 (en) * | 1991-09-14 | 1991-10-30 | Pfizer Ltd | Therapeutic agents |
GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
GB9423911D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
CA2288910C (en) * | 1997-04-25 | 2003-06-24 | Pfizer Inc. | Pyrazolopyrimidinones for sexual dysfunction |
KR100297814B1 (ko) * | 1998-12-29 | 2001-10-26 | 조민호 | 피라졸로피리미디논유도체와이의제조방법그리고이의용도 |
-
1999
- 1999-11-09 KR KR19990049384A patent/KR100353014B1/ko active IP Right Grant
- 1999-11-10 AU AU10817/00A patent/AU760422B2/en not_active Expired
- 1999-11-10 WO PCT/KR1999/000675 patent/WO2000027848A1/en active IP Right Grant
- 1999-11-10 DK DK99954478T patent/DK1129093T3/da active
- 1999-11-10 CA CA002350538A patent/CA2350538C/en not_active Expired - Lifetime
- 1999-11-10 JP JP2000581026A patent/JP3577630B2/ja not_active Expired - Lifetime
- 1999-11-10 CN CNB998127752A patent/CN1136219C/zh not_active Expired - Lifetime
- 1999-11-10 EP EP99954478A patent/EP1129093B1/en not_active Expired - Lifetime
- 1999-11-10 DE DE69909818T patent/DE69909818T2/de not_active Expired - Lifetime
- 1999-11-10 NZ NZ511015A patent/NZ511015A/en not_active IP Right Cessation
- 1999-11-10 US US09/831,433 patent/US6583147B1/en not_active Expired - Lifetime
- 1999-11-10 TR TR2001/01335T patent/TR200101335T2/xx unknown
- 1999-11-10 AT AT99954478T patent/ATE245650T1/de active
- 1999-11-10 BR BRPI9915822A patent/BRPI9915822B8/pt not_active IP Right Cessation
- 1999-11-10 PT PT99954478T patent/PT1129093E/pt unknown
- 1999-11-10 ES ES99954478T patent/ES2204169T3/es not_active Expired - Lifetime
-
2002
- 2002-01-25 HK HK02100595.7A patent/HK1039328B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69909818D1 (de) | 2003-08-28 |
KR100353014B1 (ko) | 2002-09-18 |
HK1039328A1 (en) | 2002-04-19 |
JP3577630B2 (ja) | 2004-10-13 |
WO2000027848A1 (en) | 2000-05-18 |
KR20000035324A (ko) | 2000-06-26 |
DK1129093T3 (da) | 2003-10-20 |
BR9915822A (pt) | 2001-08-14 |
CA2350538A1 (en) | 2000-05-18 |
US6583147B1 (en) | 2003-06-24 |
PT1129093E (pt) | 2003-12-31 |
NZ511015A (en) | 2003-09-26 |
ATE245650T1 (de) | 2003-08-15 |
HK1039328B (zh) | 2004-06-25 |
AU1081700A (en) | 2000-05-29 |
CA2350538C (en) | 2005-06-28 |
ES2204169T3 (es) | 2004-04-16 |
EP1129093A1 (en) | 2001-09-05 |
AU760422B2 (en) | 2003-05-15 |
DE69909818T2 (de) | 2004-05-27 |
JP2002529467A (ja) | 2002-09-10 |
EP1129093B1 (en) | 2003-07-23 |
TR200101335T2 (tr) | 2001-09-21 |
BRPI9915822B8 (pt) | 2021-05-25 |
CN1136219C (zh) | 2004-01-28 |
CN1325398A (zh) | 2001-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9915822B1 (pt) | derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência | |
LU90856I2 (fr) | Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables | |
IL162214A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
MXPA02002249A (es) | Composiciones farmaceuticas agradables al paladar para animales de compania. | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
BRPI0415179A (pt) | derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas | |
BR9911060A (pt) | Composições compreendendo mono- ou dinitrato orgânico para tratar impotência | |
EA200100516A1 (ru) | Производные 3,3-биарилпиперидина и 2,2-биарилморфолина | |
BR9907655A (pt) | Derivados de ácido di-hidróxi-hexanóico | |
DK1109814T3 (da) | 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion | |
ES2180737T3 (es) | Conjugado para la dosificacion individual de medicamentos, su procedimiento de preparacion y su uso en los mismos. | |
ATE267816T1 (de) | Tan-1057 derivate | |
PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
AR012457A1 (es) | Proceso para preparar una composicion de asfalto | |
BR0309996A (pt) | Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias | |
NO970178L (no) | Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler | |
PL340459A1 (en) | Agonists of 5ht1f | |
EA199800368A1 (ru) | Новые промежуточные продукты и их использование для получения n,n'-мостиковых бисиндолилмалеимидов | |
TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
ITMI950132A1 (it) | Derivati tiolici ad attivita' inibitrice delle metallopeptidasi | |
BR0214644A (pt) | Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação | |
BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto | |
NO20010624D0 (no) | N-substituerte azacykloheptanderivater, fremstilling og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] |
Free format text: REF. AO DESPACHO 9.1 DA RPI 2147 DE 28/02/2012 POR TER SIDO EFETUADO COM O TITULO INCORRETO |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/08/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/11/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 10/11/2019 |